All Things Biosimilar
All Things Biosimilar
Stay on the pulse of the U.S. biosimilars industry with All Things Biosimilar. Hosted by Andrew Bourgoin, founder of Bourgoin Insights Group, this podcast is your source for timely insights into the dynamic biosimilar market. Each episode unpacks the latest developments, including in-depth analysis of the U.S. retina market, the competitive dynamics for ustekinumab and aflibercept biosimilars, and what to watch for in quarterly earnings. If you need to understand the forces driving the market today, this is the podcast for you. Subscribe to stay informed.